Isoniazid Preventive Therapy
Adherence to Isoniazid Preventive Therapy (IPT) among Children in Close Contact with Adult Pulmonary Tuberculosis (PTB) Patients
8
Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation
7
Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study
9
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study
11
Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
8
Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
5
Prevalence and Factors Associated With Initiation of Isoniazid Preventive Therapy among Children Aged Below Five Years in Kisumu County
8
Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi
8
Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia
6
The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta analysis
9
Isoniazid Preventive Therapy Associated Hepatotoxicity among Children Living with HIV: Descriptive Case Series at Mildmay Uganda HIV/AIDS Clinic, Uganda
8
Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
8
Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study
12
Self-reported adherence and associated factors to isoniazid preventive therapy for latent tuberculosis among people living with HIV/AIDS at health centers in Gondar town, North West Ethiopia
7
Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya – a cohort study
11
Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews
10
Acceptability and adherence to Isoniazid preventive therapy in HIV infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
8
Human immunodeficiency virus associated tuberculosis care in Botswana: evidence from a real world setting
9
Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa
9
Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
7